ES2079743T3 - Tableta para chupar o masticar. - Google Patents

Tableta para chupar o masticar.

Info

Publication number
ES2079743T3
ES2079743T3 ES92110680T ES92110680T ES2079743T3 ES 2079743 T3 ES2079743 T3 ES 2079743T3 ES 92110680 T ES92110680 T ES 92110680T ES 92110680 T ES92110680 T ES 92110680T ES 2079743 T3 ES2079743 T3 ES 2079743T3
Authority
ES
Spain
Prior art keywords
alkaline
weight
acid
edible
tablet
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92110680T
Other languages
English (en)
Inventor
Gerhard Dr Gergely
Thomas Dr Gergely
Irmgard Gergely
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of ES2079743T3 publication Critical patent/ES2079743T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0216—Solid or semisolid forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/22—Gas releasing
    • A61K2800/222—Effervescent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Confectionery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

LA TABLETA DESLEIBLE O MASTICABLE CONTIENE COMO BASE AL MENOS 30, PERO PREFERENTEMENTE 50 HASTA 70% EN PESO, DE UNA SAL ALCALINA Y/O ALCALINOTERREA DE AL MENOS UN ACIDO COMESTIBLE ORGANICO; AL MENOS 10, PREFERENTEMENTE 20 HASTA 40% EN PESO, DE UNA MEZCLA DE AL MENOS UN ACIDO NO REACTIVO, COMESTIBLE, ORGANICO CON AL MENOS UN CARBONATO Y/O BICARBONATO NO REACTIVO ALCALINO Y/O ALCALINOTERREO ASI COMO, DADO EL CASO, UNA SUSTANCIA ACTIVA FARMACEUTICA Y/O LAS SUSTANCIAS AUXILIARES PARA TABLETAS USUALES COMO AROMATIZANTES Y EDULCORANTES, SUSTANCIAS AUXILIARES DE DESINTEGRACION, HIDROCOLOIDES, ETC. CONTIENE ESENCIALMENTE LA SAL BIBASICA ALCALINA Y/O ALCALINOTERREA DE UN ACIDO TRIBASICO, COMESTIBLE, ORGANICO, ESPECIALMENTE DEL ACIDO CITRICO, ASI COMO PREFERENTEMENTE UN ACIDO COMESTIBLE, ORGANICO, ESPECIALMENTE SOLO REACTIVO PARCIALMENTE CON LA SAL ALCALINA Y/O ALCALINOTERREA, ESPECIALMENTE ACIDO MALICO, QUE ES MAS FUERTE QUE EL ACIDO TRIBASICO ASI COMO, DADO EL CASO, REFERIDO AL PESO TOTAL DE LA TABLETA, DE 1 HASTA 10, PREFERENTEMENTE 3 HASTA 7% EN PESO, DE AL MENOS UN AGENTE DISPERSANTE, ESPECIALMENTE UN 3% EN PESO DE ALMIDON Y POLIVINILPOLIPIRROLIDONA RETICULADA TRANSVERSAL.
ES92110680T 1991-07-01 1992-06-25 Tableta para chupar o masticar. Expired - Lifetime ES2079743T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH194391 1991-07-01

Publications (1)

Publication Number Publication Date
ES2079743T3 true ES2079743T3 (es) 1996-01-16

Family

ID=4222226

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92110680T Expired - Lifetime ES2079743T3 (es) 1991-07-01 1992-06-25 Tableta para chupar o masticar.

Country Status (8)

Country Link
US (1) US5312626A (es)
EP (1) EP0525388B1 (es)
JP (1) JP3372053B2 (es)
AT (1) ATE128027T1 (es)
CA (1) CA2072513C (es)
DE (1) DE59203732D1 (es)
DK (1) DK0525388T3 (es)
ES (1) ES2079743T3 (es)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2700669B1 (fr) * 1993-01-22 1995-04-14 Tassoni Jean Pierre Composition effervescente pour la préparation de boissons gazeuses.
ATE173614T1 (de) * 1993-09-09 1998-12-15 Gerhard Gergely Brausegranulat und verfahren zu seiner herstellung
DE4333190C2 (de) * 1993-09-29 1996-05-30 Korsatko Werner Univ Prof Dr E Zerbeißtablette mit verzögerter Wirkstoff-Freisetzung
KR100395022B1 (ko) * 1994-04-22 2005-11-28 디보나 홀딩 아게 치아플라크중화효과가있는캔디
US6352713B1 (en) 1999-12-01 2002-03-05 Drugtech Corporation Nutritional composition
US6488956B1 (en) * 1994-06-20 2002-12-03 Drugtech Corporation Multi-vitamin and mineral supplements for women
DE19502789A1 (de) * 1995-01-28 1996-08-01 Dirk Krischenowski Arzneimittel
FR2732217B1 (fr) * 1995-03-29 1997-06-06 Hesnard Xavier Forme d'administration solide a usage oral
US5869095A (en) * 1995-07-31 1999-02-09 Gerhard Gergely Chewable tablet with an effervescent action
EP2179726A3 (en) * 1995-12-26 2012-09-26 Block Drug Company, Inc. Dietary fiber inulin delivery system
US6974595B1 (en) * 1996-05-17 2005-12-13 Proethic Pharmaceuticals, Inc. Pharmaceutical compositions based on Diclofenae
DE19649730A1 (de) * 1996-08-08 1998-02-12 Eu Rho Pharma Gmbh Mittel zur Stärkung des menschlichen Organismus
US6358060B2 (en) * 1998-09-03 2002-03-19 Jsr Llc Two-stage transmucosal medicine delivery system for symptom relief
US6344222B1 (en) 1998-09-03 2002-02-05 Jsr Llc Medicated chewing gum delivery system for nicotine
US6261600B1 (en) * 1999-04-30 2001-07-17 Drugtech Corporation Folic acid supplement
DE19962251A1 (de) * 1999-12-22 2001-09-06 Hermes Fabrik Pharm Praeparate Lutschtablette
AU2001261744A1 (en) * 2000-05-19 2001-12-03 Npd Llc Chewing gums, lozenges, candies, tablets, liquids, and sprays for efficient delivery of medications and dietary supplements
GB0012261D0 (en) * 2000-05-19 2000-07-12 Astrazeneca Ab Novel process
JP2002087965A (ja) * 2000-09-14 2002-03-27 Lion Corp 口中崩壊性アスピリン含有錠剤
FR2822700B1 (fr) * 2001-04-03 2007-04-06 Frederic Dana Nouveau produit d'hygiene dentaire sous forme de nutricament unidose gelifiant d'action prolongee et compositions nouvelles adaptees en comprime ou gel semisolide
US7982008B2 (en) 2002-11-27 2011-07-19 David Bar-Or Treatment of diseases and conditions mediated by increased phosphorylation
EP1663196A2 (en) * 2003-09-25 2006-06-07 DMI Biosciences, Inc. Methods and products which utilize n-acyl-l-aspartic acid
JP4917255B2 (ja) * 2003-10-16 2012-04-18 第一三共ヘルスケア株式会社 サリチル酸類含有経口組成物
US8216610B2 (en) 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
EP3216445A1 (en) * 2004-05-28 2017-09-13 Imaginot Pty Ltd. Oral therapeutic compound delivery system
US7998500B2 (en) * 2005-08-04 2011-08-16 Vertical Pharmaceuticals, Inc. Nutritional supplement for women
US7901710B2 (en) * 2005-08-04 2011-03-08 Vertical Pharmaceuticals, Inc. Nutritional supplement for use under physiologically stressful conditions
US8202546B2 (en) * 2005-08-04 2012-06-19 Vertical Pharmaceuticals, Inc. Nutritional supplement for use under physiologically stressful conditions
US8263137B2 (en) * 2005-08-04 2012-09-11 Vertical Pharmaceuticals, Inc. Nutritional supplement for women
EP3263117A1 (en) * 2005-11-28 2018-01-03 Imaginot Pty Ltd. Oral therapeutic compound delivery system
DE102006029233A1 (de) * 2006-06-26 2007-12-27 Liedtke, Rainer K., Dr. Formulierungen zur Verbesserung der Verträglichkeit nichtsteroidaler Antiphlogistika
US8642016B2 (en) * 2006-07-21 2014-02-04 Jsrnti, Llc Medicinal delivery system, and related methods
US20100009012A1 (en) * 2008-07-11 2010-01-14 Zukkoor N David Chewable pharyngeal inflammation symptom relief composition
EP2441436A1 (de) * 2010-10-13 2012-04-18 Fresenius Medical Care Deutschland GmbH Phosphatbinderformulierung zur einfachen Einnahme
US20140371174A1 (en) 2013-06-12 2014-12-18 The Procter & Gamble Company Effervescent Dosage Form
RU2014149581A (ru) 2012-06-12 2016-07-10 Дзе Проктер Энд Гэмбл Компани Шипучая лекарственная форма
JP7299876B2 (ja) * 2017-05-04 2023-06-28 ウォルター ショーブ 病原性感染の処置のための組成物及び処置手順

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2984543A (en) * 1957-03-19 1961-05-16 Pierre F Smith Stabilization of effervescent carbonate powders
FR1484202A (fr) * 1965-07-05 1967-06-09 Andreu Sa Dr Procédé de préparation d'un composé acide pour compositions effervescentes
US3887700A (en) * 1969-11-28 1975-06-03 Aspro Nicholas Ltd Analgesic formulations
US4664915A (en) * 1981-07-01 1987-05-12 Bristol-Myers Company Compressed and formed alkaline component suitable for use in buffered aspirin product
DE3440288C2 (de) * 1984-11-05 1987-03-12 Gergely, Gerhard, Dr.-Ing., Wien Pharmazeutische Zubereitung mit einem Gehalt an Ibuprofen sowie Verfahren zu ihrer Herstellung
US4650669A (en) * 1985-07-30 1987-03-17 Miles Laboratories, Inc. Method to make effervescent calcium tablets and calcium tablets produced thereby
GB8525348D0 (en) * 1985-10-15 1985-11-20 Nicholas Kiwi Pacific Pty Ltd Effervescent tablets
FR2593065B1 (fr) * 1986-01-22 1988-09-09 Smith Kline French Lab Couples effervescents, compositions effervescentes d'antagonistes h2 de l'histamine les contenant et leur preparation.
DE3627475A1 (de) * 1986-06-26 1988-01-14 Gergely Gerhard Verfahren zum herstellen eines brausegranulates, danach hergestelltes brausegranulat sowie dessen verwendung
US4867989A (en) * 1986-09-09 1989-09-19 Warner-Lambert Company Chewing gum mineral supplement
US5096714A (en) * 1988-06-28 1992-03-17 Hauser-Kuhrts, Inc. Prolonged release drug tablet formulations
US5064656A (en) * 1989-11-14 1991-11-12 Dr. Gergely & Co. Uncoated pharmaceutical reaction tablet

Also Published As

Publication number Publication date
DK0525388T3 (da) 1996-02-05
JP3372053B2 (ja) 2003-01-27
EP0525388A1 (de) 1993-02-03
ATE128027T1 (de) 1995-10-15
JPH05186334A (ja) 1993-07-27
DE59203732D1 (de) 1995-10-26
CA2072513C (en) 2002-03-26
CA2072513A1 (en) 1993-01-02
EP0525388B1 (de) 1995-09-20
US5312626A (en) 1994-05-17

Similar Documents

Publication Publication Date Title
AR003014A1 (es) Tableta masticable con efecto efervescente
US5635209A (en) Stabilized composition of levothyroxine sodium medication and method for its production
ECSP941148A (es) Medicamento en forma de comprimido con liberacion retardada de substancia activa
PE20050464A1 (es) Formulacion farmaceutica de la sal sodica del telmisartan
FR2559389B1 (fr) Procede pour la preparation de compositions pharmaceutiques a liberation soutenue, ayant une forte teneur en ingredient actif
ES2003293A6 (es) Procedimiento de obtencion de 5-arilalquil-4-alcoxy-2(5h)-furanonas
ES2129048T3 (es) Composicion estabilizada de hormona paratiroide.
EA200500891A1 (ru) Фармацевтические композиции, содержащие щелочные или соответственно кислые лекарственные соединения, поверхностно-активное вещество и физиологически приемлемую водорастворимую кислоту или соответственно основание
ES2076279T3 (es) Medicamentos que, como principio activo, contienen acidos carboxilicos con contenido en azufre, asi como su empleo para combatir retrovirus.
ES2136157T3 (es) Producto granular o comprimido que contiene un sistema efervescente y una sustancia farmaceutica activa, asi como un procedimiento para su preparacion.
ES2051800T3 (es) Tableta cubierta de dihidropiridina.
CA2339013A1 (en) Acid-triggered release microcapsules
PT1207756E (pt) Utilizacao de espinosade ou de uma formulacao que compreende espinosade
AR012480A1 (es) Una unidad de dosis farmaceutica que comprende tibolona, un metodo para elaborarla y el uso de un producto de almidon como vehiculo en unidades dedosis farmaceuticas que comprenden tibolona
ES2173267T3 (es) Soluciones farmaceuticas salinas no inorganicas para la administracion endonasal de una calcitonina
ES2530791T3 (es) Formulación de ibandronato de altas dosis
MX9400800A (es) Un complejo de estabilizacion neutro para ci-979 hci, un activador de la cognicion.
EA199900102A1 (ru) Таблетка малеата тримебутина, покрытая оболочкой
ES2136139T3 (es) Componente farmaceutico de accion ralentizada que contiene acido bilico como componente activo.
ES8301629A1 (es) "un metodo de fabricacion de una composicion farmaceutica de liberacion retardada en forma de pastillas que contiene como agente terapeutico ibuprofen o flurbiprofen".
AR019899A1 (es) Composicion farmaceutica y un procedimiento para prepararla.
ES2088445T3 (es) Tabletas masticables de sucralfato.
NO307548B1 (no) Tablett med forbedret biologisk tilgjengelighet inneholdende diklormetylendifosfonsyre som aktiv forbindelse
ES513822A1 (es) Procedimiento para la produccion de aerosoles acuosos insecticidas y acaricidas.
ES2063412T3 (es) Tableta y granulado que contienen como principio activo mesna.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 525388

Country of ref document: ES